IMO-3100 - Idera
Idera Pharma: BIO CEO & Investor Conference (Idera Pharmaceuticals, Inc) - Feb 13, 2013 - Anticipated presentation of full P2 proof-of-concept data for psoriasis in Q2 2013 
Anticipated P2 data Psoriasis
http://www.veracast.com/bio/ceoinvestor2013/main/events/1211_iderap/pdf/Idera_Pharmaceuticals.pdf
 
Feb 13, 2013
 
.
 
48a33866-1e90-423e-aef5-9ae0a0cb897e.jpg